Pfizer to Raise Prices of its 41 Drugs in the US, in January 2019

 Pfizer to Raise Prices of its 41 Drugs in the US, in January 2019

Pfizer & Eli Lilly Report Results of Tanezumab in Long-Term P-III Study for Osteoarthritis

Shots:

  • Pfizer plans to hike in drug with 5% for 36 of its drug, 3% for three and 9% for one, will be implemented in Jan 2019
  • Additionally, the current price of the drugs will remain unchanged till the end of year 2018 or 15 Jan, 2019 or until the president’s drug pricing plan is into action
  • In H2’18, Pfizer had planned for the hike in prices of drugs, which was not implemented due to pressure from the US President Donald Trump

 Click hereto read full press release/ article | Ref: Pfizer| Image: Axios

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post